Can anyone add to this discussion? What companies are far along in this MR-linac procedure.
and where are they as far as getting FDA approval? Someone once told me the ideal radiosurgery treatment would be an MRI linac on a robotic arm.
Thanks for valuable information which you always give reliably. For an example of how message boards can be wrecked by shorts and manipulators, check out RMTI. Also hemmer, you might find interesting on ISRG board my thread Dr Frederic Moll
My only reason for posting is desire to share factors for successful long time investing at my advanced age. Do not have a one year target for ISRG. Have followed ARAY since successful cyberknife treatment in 08, but so far it is a good example of a medical device company where the stock has gyrated but mostly languished due to lack of ability to make profits with their disruptive technology.
The important message in evaluating investments in medical stocks. PPS will gyrate wildly for years, and then if management has the skill to make large profits with their disruptive technology, investors at low prices will be rewarded with large returns.. JMHO
Good background for newbies to this amazing stock. If you google Dr Moll and understand the evolution of the technology and the company, you will be fascinated by the factors leading to the great results now. Vital to it all was the business management skill of Lonnie Smith in the complex medical device industry and how they were able to roll out the DaVinci system in the face of huge inertial resistance.. Much to study relating to evaluation of future stock market opportunities.
Like I've said on this board since 03 (when there were lots of intelligent posts and very few stupid ones). nobody can predict or influence short time pps, but RMTI has good potential to be a long term multibagger if management has the skill to make large profits from their disruptive technology(see ISRG). Unfortunately this will be on page 10 by this afternoon. JMHO
Investor in limited number of selected low priced stocks since 1970. This stock is appealing because of the industry they are in, the people investing in it, the $200+ m sales with close to profitability and the low number of shares outstanding. These have been the characteristics of stocks that can do well regardless of macro market. JMHO
Again. I have no specific information, but believe the reluctance to put out information comes from the fact that there are ongoing discussions and that details are not resolved. There was some embarrassment years ago when Triferic was known as SFP and statements were made about when certain things would happen that did not come to pass. Hence the reluctance now. Also, JMHO but calcitroil is a commodity with many competitors and not a disruptive technology like Triferic, so could not understand why it would be an important profit producer.
I also believe a motivator for management is to continue on this journey they started 20 years ago and provide dialysis patients with an iron replacement option that is more convenient and leaves them feeling better than the current procedure.
RMTI investor since 02, live near Wixom and am familiar with facilities and people. This is not a speculative biotech company with possibly promising future drug possibilities but high debt and many shares outstanding as explained by jack2reynolds. The question is, will management sell the company for a life of luxury before long and provide themselves and shareholders with some relatively small premium above market pps or are they up to the hard work and brilliant deal making required to produce large profits from their disruptive technology and high multibagger returns? I believe they will do the latter. Just MHO, have no special information but long time success in these types of situations.